1. Home
  2. USEG vs ACRV Comparison

USEG vs ACRV Comparison

Compare USEG & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Energy Corp. (DE)

USEG

U.S. Energy Corp. (DE)

HOLD

Current Price

$1.04

Market Cap

46.5M

Sector

Energy

ML Signal

HOLD

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$1.35

Market Cap

52.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USEG
ACRV
Founded
1966
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.5M
52.4M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
USEG
ACRV
Price
$1.04
$1.35
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$3.50
$11.67
AVG Volume (30 Days)
9.8M
707.6K
Earning Date
03-13-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
55.21
15.13
EPS
N/A
N/A
Revenue
$32,379,000.00
N/A
Revenue This Year
$79.53
N/A
Revenue Next Year
$169.01
$691.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$1.05
52 Week High
$2.75
$3.56

Technical Indicators

Market Signals
Indicator
USEG
ACRV
Relative Strength Index (RSI) 49.01 33.67
Support Level $0.94 $1.22
Resistance Level $1.09 $1.44
Average True Range (ATR) 0.06 0.10
MACD -0.01 -0.02
Stochastic Oscillator 49.29 4.55

Price Performance

Historical Comparison
USEG
ACRV

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks: